EZH2 Expression and Response to Neoadjuvant Endocrine Therapy in Estrogen Receptor Positive Invasive Breast Cancer

被引：0
|
作者：
Fineberg, Susan [1 ]
Gan, Yujun [1 ]
机构：
[1] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [21] The Survival Benefit of Endocrine Therapy in Low Estrogen Receptor Positive/HER2 Negative Invasive Breast Cancer
    Alhamar, Mohamed
    Alkamachi, Bassam
    Mehrotra, Harshita
    Ohan, Hovsep
    Ali, Haythem
    Gupta, Nilesh
    Hassan, Oudai
    Chitale, Dhananjay
    Schultz, Daniel
    Allo, Ghassan
    Alkhoory, Wamidh
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 74 - 76
  • [22] The Survival Benefit of Endocrine Therapy in Low Estrogen Receptor Positive/HER2 Negative Invasive Breast Cancer
    Alhamar, Mohamed
    Alkamachi, Bassam
    Mehrotra, Harshita
    Ohan, Hovsep
    Ali, Haythem
    Gupta, Nilesh
    Hassan, Oudai
    Chitale, Dhananjay
    Schultz, Daniel
    Allo, Ghassan
    Alkhoory, Wamidh
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 74 - 76
  • [23] Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer A Systematic Review and Meta-analysis
    Spring, Laura M.
    Gupta, Arjun
    Reynolds, Kerry L.
    Gadd, Michele A.
    Ellisen, Leif W.
    Isakoff, Steven J.
    Moy, Beverly
    Bardia, Aditya
    JAMA ONCOLOGY, 2016, 2 (11) : 1477 - 1486
  • [24] Neoadjuvant endocrine therapy for estrogen receptor (ER) positive breast cancer: Comprehensive systematic review and meta -analysis
    Spring, L.
    Gupta, A.
    Reynolds, K. L.
    Gadd, M. A.
    Isakoff, S. J.
    Ellisen, L. W.
    Moy, B.
    Bardia, A.
    CANCER RESEARCH, 2016, 76
  • [25] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77
  • [26] Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer
    Yamashita, H.
    Nishio, M.
    Ando, Y.
    Zhang, Z.
    Hamaguchi, M.
    Mita, K.
    Kobayashi, S.
    Fujii, Y.
    Iwase, H.
    ENDOCRINE-RELATED CANCER, 2006, 13 (03) : 885 - 893
  • [27] Metabolomic rewiring in endocrine therapy resistant estrogen receptor positive breast cancer
    Ahn, Songyeon
    Park, Junhyoung
    Grimm, Sandra L.
    Piyarathna, Badrajee Wb
    Putluri, Nagireddy
    Das, Gokul
    Coarfa, Cristian
    Kaipparettu, Benny A.
    CANCER RESEARCH, 2023, 83 (07)
  • [28] microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Erin W. Howard
    Xiaohe Yang
    Biological Procedures Online, 2018, 20
  • [29] microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Howard, Erin W.
    Yang, Xiaohe
    BIOLOGICAL PROCEDURES ONLINE, 2018, 20
  • [30] Neoadjuvant use of endocrine therapy in elderly patients with estrogen receptor-positive breast cancer: Series of a general hospital
    Munoz-Sanchez, M. M.
    Santiago-Crespo, J. A.
    Molina-Garrido, M. J.
    Haro-Martinez, L.
    Ortega-Ruiperez, C.
    Olaverri-Hernandez, A.
    BREAST, 2011, 20 : S75 - S75
12345